Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)
Nigeria
· Delayed Price · Currency is NGN 3.160
0.00 (0.00%)
At close: May 13, 2025
NGX:NEIMETH Revenue
In the year 2024, Neimeth International Pharmaceuticals had annual revenue of 4.49B NGN with 102.98% growth. Neimeth International Pharmaceuticals had revenue of 1.39B in the quarter ending December 31, 2024, with 99.06% growth.
Revenue
4.49B
Revenue Growth
+102.98%
P/S Ratio
3.01
Revenue / Employee
22.88M
Employees
196
Market Cap
13.50B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.49B | 2.28B | 102.98% |
| Dec 31, 2023 | 2.21B | -709.73M | -24.31% |
| Dec 31, 2022 | 2.92B | 216.47M | 8.01% |
| Sep 30, 2022 | 2.70B | -343.81M | -11.28% |
| Sep 30, 2021 | 3.05B | 207.54M | 7.31% |
| Sep 30, 2020 | Pro | Pro | Pro |
| Sep 30, 2019 | Pro | Pro | Pro |
| Sep 30, 2018 | Pro | Pro | Pro |
| Sep 30, 2017 | Pro | Pro | Pro |
| Sep 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BUA Foods | 1,613.06B |
| Dangote Cement | 3,757.86B |
| MTN Nigeria Communications | 3,665.82B |
| Geregu Power | 118.46B |
| BUA Cement | 1,006.16B |
| Transcorp Power | 343.52B |
| Aradel Holdings | 679.85B |
| Zenith Bank | 2,315.03B |